DRUG
BetaShares Global Healthcare Currency Hedged ETF
๐ฆ๐บ ASX
๐ฉบ HEALTH CARE
๐ GLOBAL
๐ Overview
๐ Performance
๐ Holdings
๐ฐ Distributions
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 5.20%
Annual Growth
5 years average annual growth
๐ฐ
3.17%
Annual distribution yield
Based on the most recent distribution
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
59
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
๐ Performance
Price History
+68.27%
1M
1Y
All Time
Graph
Table
How could long term investing grow your wealth?*
Based on an initial investment of
$
and recurring investments every
for
$
Your wealth could grow to...
$70,304.11
after 5 years
$159,501.47
after 10 years
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ Top Holdings
Show moreKRW - KOREAN WON
JPY - JAPANESE YEN
GBP - BRITISH POUND
EUR - EURO
DKK - DANISH KRONE
CHF - SWISS FRANC
AUD - AUSTRALIA DOLLAR
Updated as of 10 February 2025
Industry Exposure
๐ Other
42%
๐ Communication
34%
๐ฉบ Health
24%
Country Exposure
๐บ๐ธ United States
72%
๐จ๐ญ Switzerland
8%
๐ฉ๐ฐ Denmark
6%
๐ฌ๐ง United Kingdom of Great Britain and Northern Ireland
5%
๐ฏ๐ต Japan
4%
๐ซ๐ท France
3%
๐ฐ Distributions
Payouts
๐ฐ Annual Distribution Yield*
3.17%
๐ฐ Annual Distribution Earnings Per $1,000 invested**
$31.72
๐ฐ Most Recent Distribution Franked Percentage Estimate
0.00%
๐ฐ Average Distribution Franked Percentage Estimate
0.00 %
๐ฐ Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Estimate your distribution
If you held
$
of DRUG, your last distribution payment(s) would have been:
$ 34.69
on Fri Jan 17 2025
$ 253.14
on Tue Jul 16 2024
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.25
0.00%
2023
$0.03
NaN%
2022
$0.02
NaN%
2021
$0.37
0.00%
2020
$0.07
0.00%
2019
$0.02
NaN%
2018
$0.20
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
๐ต Costs
๐ผ
0.57%
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$8.38
๐ฐ Price To Earnings Ratio
26.09
๐ฐ Price To Book Ratio
4.88
๐ฐ Leveraged
No
๐ฐ Inverse
No
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in DRUG
59
๐ Total Capital Earnings
$100K
๐ Average investment frequency
31 weeks
๐ต Average investment amount
$2,506
โฐ Last time a customer invested in DRUG
10 days
DRUG investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
7%
100k - 150k
17%
50k - 100k
45%
Less than 50k
25%
๐ถ Age of investors
18 - 25
26 - 34
49%
35 - 90
44%
๐ Legal gender of investors
Female
64%
Male
36%
Pearlers who invest in DRUG also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
3.17%
๐ Share price
$102.68 AUD
๐งฑ MATERIALS
โณ๏ธ DIVERSIFIED
๐ธ FINANCIALS
๐ฆ๐บ AUSTRALIA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
3.37%
๐ Share price
$69.61 AUD
โณ๏ธ DIVERSIFIED
๐ GLOBAL
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
18.18%
๐ Share price
$63.70 AUD
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
12.88%
๐ Share price
$142.08 AUD
๐ค TECHNOLOGY
๐ GLOBAL
๐ HIGH PRICE GROWTH
โณ๏ธ DIVERSIFIED
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
๐ Performance (5Yr p.a)
10.15%
๐ Share price
$16.22 AUD
๐ธ FINANCIALS
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
๐ GLOBAL
๐ค TECHNOLOGY
Want more shares? Try these...
Diatreme Resources Ltd. engages in the exploration of mineral sands, copper, gold and base metals in Australia. The company is headquartered in Brisbane, Queensland. The company went IPO on 2005-06-22. The Companyโs key projects comprise the Northern Silica Project and Galalar Silica Sand Project in Far North Queensland, located next to the silica sand mine at Cape Flattery. Its flagship project, the Northern Silica Project is located about 35 kilometers (km) north of Hope Vale and 14 km west of the Port of Cape Flattery in Far North Queensland. The Galalar Silica Sands Project is situated near Cape Bedford, about 20 km from Hope Vale. Galalar Silica Project is engaged in producing silica for the solar panel market. Its Cyclone Mineral Sands Project is situated about 317 km north of Eucla and 220 km north of the Trans-Australia Railway in the vast expanse of the Eucla Basin. Its Clermont Copper/Gold Project is located around the town of Clermont in central Queensland for exploring porphyry copper/gold and mesothermal gold. The company also holds interest in the Cape Flattery Silica Sand Project.
๐ Performance (5Yr p.a)
12.73%
๐ Share price
$0.02 AUD
๐ HIGH PRICE GROWTH
โ๏ธ MINING
Deterra Royalties Ltd. engages in the business of management and growth of a portfolio of royalty assets across a range of companies focuses on bulk, base, and battery metals. The company is headquartered in Perth, Western Australia and currently employs 11 full-time employees. The company went IPO on 2020-10-23. The Companyโs portfolio includes royalties held over Mining Area C, its cornerstone asset, in the Pilbara region of Western Australia, as well as five smaller royalties, including Yoongarillup/Yalyalup, Wonnerup, Eneabba and St Ives. Its key royalty investment activities involve acquisition of royalties from third parties and providing finance to resource companies in return for royalties. The Companyโs projects include Mining Area C (MAC), Yoongarillup / Yalyalup Mineral Sands Mines, Wonnerup Mineral Sands, St Ives Gold Project and Eneabba Project. MAC is located approximately 90 kilometers (km) northwest of Newman Township in the Pilbara region of Western Australia, which is an iron ore province. MAC produces approximately 145 million tons of iron ore per annum.
๐ Share price
$3.85 AUD
โ๏ธ MINING